590 likes | 1.44k Views
GP Practice Update. Lynn Orford Community Respiratory Team and HOSAR Lead. Spirometry. Guidelines published by the PCC in 2013 National recommendation for Diagnostic Spirometry to be quality assured come into effect 2020. Equipment. A spirometer that meets the correct industry standard
E N D
GP Practice Update Lynn Orford Community Respiratory Team and HOSAR Lead
Spirometry • Guidelines published by the PCC in 2013 • National recommendation for Diagnostic Spirometry to be quality assured come into effect 2020
Equipment • A spirometer that meets the correct industry standard • One way mouthpieces and nose clips • Bacterial / viral filters • Height measure and weighing scales For reversibility testing • Nebuliser or single patient use volumatics • Short acting broncholdilator
Calibration • Need a 3 litre syringe • This needs to be checked annually to ensure accuracy to within 15 ml • Calibrate before every session ( or 10 patients) • Document calibration/ verification
Cleaning • Regular cleaning schedule • Document schedule • Need appropriate cleaning solution to the machine.
Reasons for spirometry • Detect the presence of lung disease • Assist in diagnosis • Classify severity • Monitor deterioration of disease • To help guide optimal medication management
Contra- indications to Spirometry • Active infection ( ideally to be 6 weeks post ) • Recent MI ( 6 weeks) • Aneurysm • Pneumothorax • Recent surgery ( 6 weeks) • Ophthalmic surgery • Communication/ability to follow instructions
Infection control • Follow general infection control • Immune compromised patients ideally at beginning of session • Known infective patients should be at the end of the session and with a filter ( if not used routinely)
The test • Is it acceptable ? • Is it repeatable ? • At least 3 forced manoeuvres – FEV1 & FVC • Graph should be smooth and free from irregularities • Exhalation – at least 6 seconds • VC, FVC– use the best one to calculate ratio • 2 best tests within 5% or 100 mL of each other
Results • Numbers • Flow volume curve / loop • Volume/time curve
Obstructive pattern • FEV1/FVC ratio less that 70% • Should also be below the lower limit of normal to help prevent false positive in the elderly and false negative in the younger age groups • FEV1 is used to measure the severity of obstruction
Restrictive Pattern • Normal or increased FEV1/FVC ratio • Low FVC • Need full lung function to determine cause • Easy to get false positive due to lack of patient cooperation or early termination leading to a falsely low FVC
Mixed pattern • Restrictive and obstructive patterns occur together • FVC and FEV1/FVC ratio below the lower limit of normal • Need full lung function e.g. Total lung capacity and gas transfer
Relievers- short acting • Short acting • First line • Examples are • Ventolin, Salbutamol, • Bricanyl, Terbutaline • Atrovent, Ipratropium bromide • Typically previously mostly came in MDI format now available in dry powder
Relievers – long acting • Long Acting • Examples are:
LABA /LAMA Combinations • Long acting • Once or twice a day • Maximal Bronchodilatation
LABA/ICS Combination Inhalers • Only 4 Licensed products used locally • Combine a long acting bronchodilator and an inhaled steroid • Seretide 500 Accuhaler – generic- Aerivio Spiromax/ Airflusal Forspiro/ Fusacomb Easyhaler • Symbicort 400/12 and 200/6 Turbohaler - generic is Duoresp Spiromax • Fostair 100/6 MDI and Nexthaler • Relvar Ellipta 92/22 NB Sirdupla / Sereflo /Airflusal / Aloflute- generic versions of Seretide 250 MDI- do not have COPD Licence
Triple Therapy • Combination of inhaled corticosteroid/ LABA/LAMA • Should only be started after seeking advice from or referring to respiratory specialist
Trimbow • Two puffs twice a day- used with a spacer
Trelegy • Once a day